Viridian Therapeutics Launches Two Phase 3 Trials: TED
Viridian Therapeutics plans to initiate two phase 3 clinical trials (REVEAL-1 and REVEAL-2) for VRDN-003, an anti-IGF-1R antibody, in...
Why Did FDA Panel Reject Psychoactive MDMA-Assisted Therapy?
The FDA Panel has raised multiple critical concerns regarding Lykos Therapeutics’ MDMA-assisted therapy trials for treating PTSD, offering valuable...
Evrysdi’s Remarkable Results: Treating Spinal Muscular Atrophy
A recent study presented at the Cure SMA Research & Clinical Care Meeting has revealed the sustained efficacy and...
First Patient Enrolled in Monotherapy Study Evaluating Camonsertib in Non-Small Cell Lung Cancer
Repare Therapeutics, a precision oncology company, has initiated patient dosing in the expanded phase of its TRESR clinical trial,...
FDA Approves GSK’s AREXVY RSV Vaccine for At-Risk Seniors over 50
The US Food and Drug Administration (FDA) has given its approval to AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) for...
Unveiling Calidi’s Breakthrough Virotherapy: Revolutionizing Cancer Treatment
Calidi Biotherapeutics, a biotechnology company focused on developing anti-tumor virotherapies, has forged a partnership with SIGA Technologies to advance...
FDA Grants Tagrisso® Priority Review for Unresectable Stage III EGFR-Mutated Lung Cancer
AstraZeneca has filed and received Priority Review status in the United States for TAGRISSO® (osimertinib) for treating adult patients...
FDA Approves Almirall’s Revolutionary New Klisyri® for Expanded Treatment of Skin Cancer
The U.S. Food and Drug Administration (FDA) has approved Almirall’s expanded use of Klisyri for actinic keratosis (AK) treatment....
AstraZeneca’s Investment Powers Nucleus Radiopharma’s Series A Extension
Nucleus RadioPharma has expanded its capabilities with a Series A investment extension and the appointment of Dr. Tyrell Rivers...
Twist Bioscience Discovery in Antibody Engineering
Twist Bioscience has unveiled TB206-001, an antibody antagonist targeting the adenosine A2A receptor (A2AR). This discovery represents a significant...